11/14
08:00 am
algs
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/10
08:40 am
algs
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025 [Yahoo! Finance]
Medium
Report
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025 [Yahoo! Finance]
11/10
08:00 am
algs
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
Low
Report
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
11/8
01:12 am
algs
Aligos Therapeutics (NASDAQ:ALGS) was downgraded by analysts at
Wall Str
Low
Report
Aligos Therapeutics (NASDAQ:ALGS) was downgraded by analysts at
Wall Str
11/6
08:30 am
algs
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
Low
Report
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
11/4
08:30 am
algs
Aligos Therapeutics to Present at Upcoming Investor Conferences
Medium
Report
Aligos Therapeutics to Present at Upcoming Investor Conferences
10/30
08:30 am
algs
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
Medium
Report
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
10/17
08:30 am
algs
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/16
08:30 am
algs
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
Low
Report
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
10/14
08:58 am
algs
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference [Yahoo! Finance]
Low
Report
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference [Yahoo! Finance]
10/14
08:30 am
algs
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
Low
Report
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
10/7
08:49 am
algs
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025 [Yahoo! Finance]
Medium
Report
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025 [Yahoo! Finance]
10/7
08:30 am
algs
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
Medium
Report
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
9/12
11:28 am
algs
Aligos Therapeutics (NASDAQ:ALGS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Aligos Therapeutics (NASDAQ:ALGS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.